Mylan N.V. (NasdaqGS:MYL) made a tender offer to acquire Meda AB (OM:MEDA A) from Stena Sessan Rederi AB, Fidim S.r.l. and others for SEK 60.4 billion in cash and stock on February 10, 2016. Under the terms of the transaction, Mylan will acquire 80% stake of Meda in cash at SEK 165 per share and balance 20% stake in stock. The offer will run from May 20, 2016 to July 29, 2016. If Mylan becomes the owner of more than 90% of the Meda shares, Mylan intends to initiate a compulsory acquisition procedure with respect to the remaining Meda shares in accordance with the Swedish Companies Act. Mylan will finance the cash portion of the offer consideration through a new bridge credit facility arranged by Deutsche Bank Securities Inc. and Goldman Sachs Bank USA. Mylan will fund the deal by placing senior note at $6.5 billion. The offer is subject to the satisfaction of a number of customary conditions, including clearance from relevant competition authorities, regulatory approval, governmental clearances, minimum tender, the Mylan shares to be issued in the offer being approved for listing on the NASDAQ Global Select Market in the United States and the Tel Aviv Stock Exchange in Israel and registration statement effectiveness. The Offer will not require a vote of Mylan shareholders. The offer has been unanimously approved by Mylan’s Board of Directors and unanimously recommended by Meda’s Board of Directors to its shareholders. The deal is expected to be completed by the end of the third quarter of 2016. The transaction is expected to be immediately accretive to Mylan earnings, with accretion increasing significantly after 2017. As of February 10, 2016, Mylan entered into a bridge credit agreement. Under this agreement, Mylan will acquire a Tranche A Loan of $6 billion (SEK 51 billion), which will applied solely to finance the acquisition of the shares of Meda and pay other costs associated with the offer etc. On June 9, 2016 the Turkish Competition Authority unconditionally approved Mylan’s acquisition of Meda. The Swedish Financial Supervisory Authority approved the deal on June 17, 2016. As of June 30, 2016, decision to approve the deal was extended till July 20, 2016, by EU. As of July 20, 2016, Mylan obtained regulatory approval from the European Commission for the deal. European Commission has approved the transaction under the EU merger regulation. The decision is conditional upon the divestment of a number of Mylan's or Meda's businesses in Austria, Belgium, Estonia, France, Luxembourg, Ireland, Italy, Norway, Portugal, Spain and the UK. The transaction was approved by U.S. Federal Trade Commission on July 27, 2016. As on August 2, 2016, Mylan N.V. announced that its recommended public offer to the shareholders of Meda to tender all their shares in Meda to Mylan has been accepted by shareholders holding an aggregate of 342.6 million shares, corresponding to approximately 94% of the total number of outstanding shares and votes in Meda. All conditions to the offer have been fulfilled and Mylan has declared the offer unconditional and will complete the offer. Settlement of the transaction is expected to occur on or around Aug. 5, 2016. The acceptance period expired on July 29, 2016 and will not be extended. As on August 2, 2016, Stena Sessan Rederi AB sold 75.6 million shares of Meda AB, representing 20.7% stake. Centerview Partners UK LLP acted as financial advisor and Thomas E. Dunn, Mark I. Greene, Aaron M. Gruber, Andrew Elken, George E. Zobitz, Eric W. Hilfers, Christine A. Varney, Yonatan Even, Matthew Morreale, Stephen L. Gordon, J. Leonard Teti II, David J. Kappos and Jonathan J. Katz of Cravath, Swaine & Moore LLP, Leo Groothius of NautaDutilh N.V. and Erik Sjöman of Advokatfirman Vinge KB acted as legal advisors to Mylan N.V. Richard Josephson, Maria Rimbäck, Ian Poppelman, Nicolai Elstrøm and Rikard Schwalbe of Skandinaviska Enskilda Banken AB (publ) (OM:SEB A) acted as financial advisors and fairness opinion provider to Meda AB. Dominic Hollamby, Stefano Beschi, Dimitrios Iroidis and Per-Olov Bergstrom of Rothschild Nordic AB acted as financial advisor to Meda. Eva Hagg, Patrik Marcelius, Johan Carle, Magnus Olsson, Therese Lundgren, Stephanie Salehian and Sofia Thelin of Mannheimer Swartling Advokatbyrå AB acted as legal advisors for Meda, Stena Sessan Rederi and Fidim. Handelsbanken Capital Markets acted as financial advisor to Mylan. Currency conversion has been done through www.oanda.com as on February 10, 2016. Mylan N.V. (NasdaqGS:MYL) completed the acquisition of Meda AB (OM:MEDA A) from Stena Sessan Rederi AB, Fidim S.r.l. and others on July 29, 2016.